Back to GetFilings.com



Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


Form 10-Q

     
þ
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the period ended October 31, 2004
 
or
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the transition period from           to

Commission File Number 0-6715


Analogic Corporation

(Exact name of registrant as specified in its charter)
     
Massachusetts   04-2454372
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
 
8 Centennial Drive,
Peabody, Massachusetts
(Address of principal executive offices)
  01960
(Zip Code)

(978) 977-3000

(Registrant’s telephone number, including area code)


(Former name, former address and former fiscal year, if changed since last report.)

          Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o

          Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).     Yes þ          No o

          The number of shares of Common Stock outstanding at December 31, 2004 was 13,688,954.




ANALOGIC CORPORATION

TABLE OF CONTENTS

             
Page No.

 Part I. Financial Information        
 Item 1.  Financial Statements        
     Unaudited Condensed Consolidated Balance Sheets as of October 31, 2004 and July 31, 2004     2  
     Unaudited Condensed Consolidated Statements of Income for the Three Months Ended October 31, 2004 and 2003 (Restated)     3  
     Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended October 31, 2004 and 2003 (Restated)     4  
     Notes to Unaudited Condensed Consolidated Financial Statements     5-15  
 Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations     16-25  
 Item 3.  Quantitative and Qualitative Disclosures about Market Risk     25  
 Item 4.  Controls and Procedures     26-27  
 Part II. Other Information        
 Item 6.  Exhibits     27  
 Signatures     28  
 Exhibit Index     29  
 EX-31.1 Certification of CEO
 EX-31.2 Certification of CFO
 EX-32.1 Certification of CEO Pursuant to Section 906
 EX-32.2 Certification of CFO Pursuant to Section 906

Introductory note:

      The Company is restating its financial statements for the quarterly period ended October 31, 2003 (the “Restatement”). All financial information reported for that quarterly period in this Quarterly Report on Form 10-Q reflects the Restatement. Please see Note 1 of Notes to Unaudited Condensed Consolidated Financial Statements for more information regarding the Restatement.

1


Table of Contents

PART I.     FINANCIAL INFORMATION

Item 1.     Financial Statements

ANALOGIC CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)
(In thousands, except per share data)
                     
October 31, July 31,
2004 2004


ASSETS
Current assets:
               
 
Cash and cash equivalents
  $ 172,167     $ 149,549  
 
Marketable securities, at market
    21,610       27,088  
 
Accounts and notes receivable, net of allowance for doubtful accounts of $2,461 at October 31, 2004 and $2,493 at July 31, 2004
    49,562       55,498  
 
Inventories
    67,103       65,952  
 
Costs related to deferred revenue
    12,412       12,723  
 
Refundable and deferred income taxes
    11,738       10,861  
 
Other current assets
    7,401       6,450  
   
   
 
   
Total current assets
    341,993       328,121  
   
   
 
Property, plant and equipment, net
    92,609       91,077  
Investments in and advances to affiliated companies
    10,325       10,967  
Capitalized software, net
    11,208       9,502  
Goodwill
    1,640       1,565  
Intangible assets, net
    8,682       9,223  
Costs related to deferred revenue
    219       219  
Other assets
    1,227       1,397  
   
   
 
   
Total Assets
  $ 467,903     $ 452,071  
   
   
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
 
Notes payable
  $ 42     $ 785  
 
Obligations under capital leases
    180       177  
 
Accounts payable, trade
    24,310       21,707  
 
Accrued liabilities
    21,912       21,380  
 
Deferred revenue
    28,467       26,281  
 
Advanced payments
    13,223       6,125  
 
Accrued income taxes
    5,894       5,791  
 
Accrued dividends payable
    1,095        
   
   
 
   
Total current liabilities
    95,123       82,246  
   
   
 
Long-term liabilities:
               
 
Obligations under capital leases
    119       155  
 
Deferred revenue
    1,459       1,459  
 
Deferred income taxes
    2,190       810  
   
   
 
   
Total long-term liabilities
    3,768       2,424  
   
   
 
Commitments and guarantees (Note 14)
               
Stockholders’ equity:
               
 
Common stock, $.05 par value
    714       713  
 
Capital in excess of par value
    48,139       47,257  
 
Retained earnings
    323,094       324,025  
 
Accumulated other comprehensive income
    3,929       2,141  
 
Unearned compensation
    (6,864 )     (6,735 )
   
   
 
   
Total stockholders’ equity
    369,012       367,401  
   
   
 
   
Total Liabilities and Stockholders’ Equity
  $ 467,903     $ 452,071  
   
   
 

The accompanying notes are an integral part of these unaudited condensed financial statements.

2


Table of Contents

ANALOGIC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share data)
                     
Three Months Ended
October 31,

2004 2003


Restated
Net revenue:
               
 
Product
  $ 76,086     $ 62,677  
 
Engineering
    5,240       6,596  
 
Other
    2,765       2,436  
   
   
 
Total net revenue
    84,091       71,709  
   
   
 
Cost of sales:
               
 
Product
    47,139       38,675  
 
Engineering
    4,062       2,804  
 
Other
    1,438       1,209  
   
   
 
Total cost of sales
    52,639       42,688  
   
   
 
Gross margin
    31,452       29,021  
   
   
 
Operating expenses:
               
 
Research and product development
    13,937       15,303  
 
Selling and marketing
    8,887       8,024  
 
General and administrative
    9,993       8,473  
   
   
 
      32,817       31,800  
   
   
 
Loss from operations
    (1,365 )     (2,779 )
   
   
 
Other (income) expense:
               
 
Interest income
    (856 )     (1,124 )
 
Interest expense
    16       73  
 
Equity (gain) loss in unconsolidated affiliates
    (117 )     157  
 
Other
    (592 )     (106 )
   
   
 
      (1,549 )     (1,000 )
   
   
 
Income (loss) before income taxes
    184       (1,779 )
Provision for income taxes
    19       (178 )
   
   
 
Net income (loss)
  $ 165     $ (1,601 )
   
   
 
Net income (loss) per common share:
               
   
Basic
  $ 0.01     $ (0.12 )
   
Diluted
    0.01       (0.12 )
Weighted average shares outstanding:
               
   
Basic
    13,521       13,381  
   
Diluted
    13,546       13,381  

The accompanying notes are an integral part of these unaudited condensed financial statements.

3


Table of Contents

ANALOGIC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)
(In thousands)
                     
Three Months Ended
October 31,

2004 2003


Restated
OPERATING ACTIVITIES:
               
Net income
  $ 165     $ (1,601 )
Adjustments to reconcile net income to net cash provided (used) by operating activities:
               
   
Deferred income taxes
    (497 )     (752 )
   
Depreciation and amortization
    5,036       5,300  
   
Allowance for doubtful accounts
    49       2  
   
(Gain) loss on sale of property, plant, and equipment
    2       (21 )
   
Equity (gain) loss in unconsolidated affiliates
    (117 )     157  
   
Equity loss in unconsolidated affiliate classified as research and product development expense
    759       1,338  
   
Non-cash compensation expense from stock grants
    526       411  
   
Net changes in operating assets and liabilities (Note 11)
    18,455       (7,065 )
   
   
 
NET CASH PROVIDED BY (USED FOR) OPERATING ACTIVITIES:
    24,378       (2,231 )
   
   
 
INVESTING ACTIVITIES:
               
 
Investments in and advances to affiliated companies
    (607 )     (19 )
 
Acquisition of assets
          (1,000 )
 
Additions to property, plant and equipment
    (3,410 )     (7,097 )
 
Capitalized software
    (1,987 )     (983 )
 
Proceeds from sale of property, plant and equipment
    16       100  
 
Maturities of marketable securities
    5,345       4,465  
   
   
 
NET CASH USED FOR INVESTING ACTIVITIES
    (643 )     (4,534 )
   
   
 
FINANCING ACTIVITIES:
               
 
Payments on debt and capital lease obligations
    (743 )     (124 )
 
Issuance of stock pursuant to exercise of stock options and employee stock purchase plan
    228       919  
   
   
 
NET CASH PROVIDED BY (USED FOR) FINANCING ACTIVITIES
    (515 )     795  
   
   
 
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
    (602 )     18  
   
   
 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
    22,618       (5,952 )
   
   
 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
    149,549       136,806  
   
   
 
CASH AND CASH EQUIVALENTS, END OF PERIOD
  $ 172,167     $ 130,854  
   
   
 

The accompanying notes are an integral part of these unaudited condensed financial statements.

4


Table of Contents

ANALOGIC CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands except per share data)
 
1. Restatement:

      Analogic Corporation (“the Company”) is restating its Consolidated Financial Statements for fiscal 2002 and 2003 and for each of the first three quarters of fiscal 2004, to reflect the application of the appropriate accounting principles to (1) the recognition of software revenue and related costs by its 100% owned U.S. subsidiary Camtronics Medical Systems, Ltd. (“Camtronics”) and (2) the treatment of a license of intellectual property sold to the Company’s affiliate Shenzhen Anke High-Tech Ltd. (“SAHCO”) for each of the first three quarters of fiscal 2004. As restated, the Company’s financial results for the quarter ended October 31, 2003 reflect a reduction in revenues of $3,260, a reduction of net income of $2,232 and a reduction in diluted earnings per share of $0.17, compared to the Company’s financial results previously reported for the quarter ended October 31, 2003.

      Summarized below is a more detailed discussion of the restatement affecting the quarter ended October 31, 2003 along with a comparison of the amounts previously reported in the Condensed Consolidated Statements of Income in the Company’s Form 10-Q for the quarter ended October 31, 2003.

     Software Revenue

      Camtronics’ revenues are derived primarily from the sales of Digital Cardiac Information Systems. System sales revenues consist of the following components: computer software licenses, computer hardware, installation support, and sublicensed software. In addition, Camtronics generates revenues related to system sales for software support, hardware maintenance, training, consulting and other professional services.

      Camtronics recognizes revenue in accordance with the provisions of American Institute of Certified Public Accountants (“AICPA”) Statement of Position 97-2, “Software Recognition” (“SOP 97-2”). SOP 97-2 requires revenue earned on software arrangements involving multiple-elements to be allocated to each element based on the fair values of those elements or by use of the residual method. Under the residual method, revenue is recognized in a multiple-element arrangement when vendor-specific objective evidence (“VSOE”) of fair value exists for all the undelivered elements in the arrangement, which is determined by the price charged when that element is sold separately (i.e. professional services, software support, hardware maintenance, hardware and sublicensed software), but does not exist for one or more of the delivered elements in the arrangement (i.e. software solutions). Specifically, Camtronics determines the VSOE of fair value of the maintenance portion of the arrangement based on the renewal price of the maintenance charged to clients; determines the VSOE of fair value of the professional services portion of the arrangement, other than installation services, based on hourly rates which Camtronics charges for these service when sold apart from a software license; and determines the VSOE of fair value of the hardware and software sublicenses based on the prices for these elements when they are sold separately from the software. If evidence of the VSOE of fair value cannot be established for the undelivered elements of a license agreement, the entire amount of revenue under the arrangement is deferred until these elements have been delivered or the VSOE of fair value for the remaining undelivered elements is established.

      Inherent in the revenue recognition process are significant management estimates and judgments, which influence the timing and amount of revenue recognition. In particular, the application of SOP 97-2 requires judgment concerning whether a software arrangement includes multiple elements; if so, whether all such elements have been delivered; and if not, whether VSOE of fair value exists for the undelivered elements.

      The restatements are required due to the incorrect application of software revenue recognition procedures with respect to certain Camtronic’s transactions. Under software revenue recognition rules, revenue cannot be recognized on a multiple-element software arrangement until such time as Camtronics has delivered or performed all elements of the arrangement or has VSOE of fair value for each undelivered or non-performed element of the arrangement. In the majority of the transactions underlying the restatement, Camtronics has

5


Table of Contents

ANALOGIC CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

delivered and the customer has paid for the software. However, revenue cannot be recognized from the transactions because some element of the transaction — such as the delivery of a software upgrade or the performance of customization services — has not been delivered or performed or VSOE of fair value for those elements cannot be determined.

 
License of intellectual property

      During the first quarter of fiscal 2004, the Company recorded engineering revenue of $2,775 in connection with the sale of a license of intellectual property to the Company’s affiliate SAHCO. The contract agreement between the Company and SAHCO provided for extended payment terms whereby SAHCO was required to make a payment of $500 within the first 30 days from the date of the contract and the balance over the next twelve months. Upon further review of the agreement, the Company has determined that this license revenue should have been recorded as the payments were received from SAHCO and not in its entirety at the date of the contract because collectibility was not reasonably assured. The Company received a total of $1,750 from SAHCO during fiscal 2004, and received an additional $750 during the quarter ended October 31, 2004.

6


Table of Contents

ANALOGIC CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The following tables show the effect of the restatement on the Company’s Statement of Income for the quarter ended October 31, 2003:

 
Statement of Income:
                             
Three Months Ended
October 31, 2003

Previously
Reported Restated Change



Net revenue:
                       
 
Product
  $ 63,912     $ 62,677     $ (1,235 )(a)
 
Engineering
    8,621       6,596       (2,025 )(b)
 
Other
    2,436       2,436          
   
   
   
 
Total net revenue
    74,969       71,709       (3,260 )
   
   
   
 
Cost of sales:
                       
 
Product
    39,308       38,675       (633 )(c)
 
Engineering
    2,804       2,804          
 
Other
    1,209       1,209          
   
   
   
 
Total cost of sales
    43,321       42,688       (633 )
   
   
   
 
Gross margin
    31,648       29,021       (2,627 )
   
   
   
 
Operating expenses:
                       
 
Research and product development
    15,303       15,303          
 
Selling and marketing
    8,083       8,024       (59 )(d)
 
General and administrative
    8,473       8,473          
   
   
   
 
      31,859       31,800       (59 )